141 related articles for article (PubMed ID: 3470806)
1. Broad spectrum antiretroviral activity of 2',3'-dideoxynucleosides.
Dahlberg JE; Mitsuya H; Blam SB; Broder S; Aaronson SA
Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2469-73. PubMed ID: 3470806
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides.
Mitsuya H; Broder S
Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1911-5. PubMed ID: 3006077
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of infectivity and replication of HIV-2 and SIV in helper T-cells by 2',3'-dideoxynucleosides in vitro.
Mitsuya H; Broder S
AIDS Res Hum Retroviruses; 1988 Apr; 4(2):107-13. PubMed ID: 2835072
[TBL] [Abstract][Full Text] [Related]
4. Long-term inhibition of human T-lymphotropic virus type III/lymphadenopathy-associated virus (human immunodeficiency virus) DNA synthesis and RNA expression in T cells protected by 2',3'-dideoxynucleosides in vitro.
Mitsuya H; Jarrett RF; Matsukura M; Di Marzo Veronese F; DeVico AL; Sarngadharan MG; Johns DG; Reitz MS; Broder S
Proc Natl Acad Sci U S A; 1987 Apr; 84(7):2033-7. PubMed ID: 2436223
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of 2',3'-dideoxynucleosides by enzymatic trans-glycosylation.
Carson DA; Wasson DB
Biochem Biophys Res Commun; 1988 Sep; 155(2):829-34. PubMed ID: 3262341
[TBL] [Abstract][Full Text] [Related]
6. 9-[(2RS)-3-fluoro-2-phosphonylmethoxypropyl] derivatives of purines: a class of highly selective antiretroviral agents in vitro and in vivo.
Balzarini J; Holy A; Jindrich J; Dvorakova H; Hao Z; Snoeck R; Herdewijn P; Johns DG; De Clercq E
Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4961-5. PubMed ID: 1711214
[TBL] [Abstract][Full Text] [Related]
7. [Antiretroviral treatments in human immunodeficiency virus infection].
Dormont J; Aboulker JP
Rev Prat; 1994 Jun; 44(12):1635-42. PubMed ID: 7939239
[TBL] [Abstract][Full Text] [Related]
8. In search of specific inhibitors of retrovirus replication.
De Clercq E; Balzarini J
Antiviral Res; 1985; Suppl 1():89-94. PubMed ID: 2417552
[No Abstract] [Full Text] [Related]
9. Adenallene and cytallene: acyclic-nucleoside analogues that inhibit replication and cytopathic effect of human immunodeficiency virus in vitro.
Hayashi S; Phadtare S; Zemlicka J; Matsukura M; Mitsuya H; Broder S
Proc Natl Acad Sci U S A; 1988 Aug; 85(16):6127-31. PubMed ID: 3261865
[TBL] [Abstract][Full Text] [Related]
10. Antiretroviral therapy.
Thiers BH
J Am Acad Dermatol; 1989 Sep; 21(3 Pt 1):443-54. PubMed ID: 2550525
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and anti-HIV activity of carbovir and related carbocyclic nucleosides.
Vince R
Nucleic Acids Symp Ser; 1991; (25):193-4. PubMed ID: 1842080
[TBL] [Abstract][Full Text] [Related]
12. Development of new potent and selective agents against HIV (human immunodeficiency virus).
Pauwels R; Schols D
Verh K Acad Geneeskd Belg; 1991; 53(6):629-55. PubMed ID: 1816706
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of herpes simplex virus replication by purine deoxyribonucleosides.
North TW
Cancer Res; 1984 Apr; 44(4):1415-9. PubMed ID: 6322976
[TBL] [Abstract][Full Text] [Related]
14. Feline leukemia virus-induced immunodeficiency syndrome in cats as a model for evaluation of antiretroviral therapy.
Hoover EA; Zeidner NS; Perigo NA; Quackenbush SL; Strobel JD; Hill DL; Mullins JI
Intervirology; 1989; 30 Suppl 1():12-25. PubMed ID: 2540109
[TBL] [Abstract][Full Text] [Related]
15. The Antiviral Activity of the Cellular Glycoprotein LGALS3BP/90K Is Species Specific.
Lodermeyer V; Ssebyatika G; Passos V; Ponnurangam A; Malassa A; Ewald E; Stürzel CM; Kirchhoff F; Rotger M; Falk CS; Telenti A; Krey T; Goffinet C
J Virol; 2018 Jul; 92(14):. PubMed ID: 29743357
[TBL] [Abstract][Full Text] [Related]
16. Antiviral activity of cyclosaligenyl prodrugs of acyclovir, carbovir and abacavir.
Balzarini J; Haller-Meier F; De Clercq E; Meier C
Antivir Chem Chemother; 2001 Sep; 12(5):301-6. PubMed ID: 11900349
[TBL] [Abstract][Full Text] [Related]
17. Suppression of feline immunodeficiency virus infection in vivo by 9-(2-phosphonomethoxyethyl)adenine.
Egberink H; Borst M; Niphuis H; Balzarini J; Neu H; Schellekens H; De Clercq E; Horzinek M; Koolen M
Proc Natl Acad Sci U S A; 1990 Apr; 87(8):3087-91. PubMed ID: 2158102
[TBL] [Abstract][Full Text] [Related]
18. Agents for treating human immunodeficiency virus infection.
Acosta EP; Fletcher CV
Am J Hosp Pharm; 1994 Sep; 51(18):2251-67; quiz 2286-7. PubMed ID: 7801986
[TBL] [Abstract][Full Text] [Related]
19. Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus.
Matsukura M; Shinozuka K; Zon G; Mitsuya H; Reitz M; Cohen JS; Broder S
Proc Natl Acad Sci U S A; 1987 Nov; 84(21):7706-10. PubMed ID: 3499613
[TBL] [Abstract][Full Text] [Related]
20. Differential susceptibility of retroviruses to nucleoside analogues.
Rosenblum LL; Patton G; Grigg AR; Frater AJ; Cain D; Erlwein O; Hill CL; Clarke JR; McClure MO
Antivir Chem Chemother; 2001 Mar; 12(2):91-7. PubMed ID: 11527046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
